Townsend & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Townsend & Associates's JNJ Position: Q3 2026 in Review
Townsend & Associates reduced its Johnson & Johnson (JNJ) stake by 14% in Q3 2026, selling an estimated $336K and leaving 7,971 shares worth $2.04M. The position accounts for 0.17% of the portfolio, ranked #59.
Townsend & Associates first reported a position in JNJ in Q4 2017 and has held it in 31 quarters since. The position peaked at $2.3M in Q2 2026. 2,215 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- Townsend & Associates held 7,971 shares of Johnson & Johnson worth $2.04M as of Q3 2026.
- Townsend & Associates sold 1,275 Johnson & Johnson shares in Q3 2026, an estimated $336K.
- Johnson & Johnson made up 0.17% of Townsend & Associates's portfolio in Q3 2026, its #59 holding.
- Townsend & Associates first reported a position in Johnson & Johnson in Q4 2017 and has held it in 31 quarters since.
- Townsend & Associates's Johnson & Johnson position peaked at $2.3M in Q2 2026.
- 2,215 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on Townsend & Associates's 13F filing for Q3 2026, filed 23 Oct 2026.